HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nefize Turan Selected Research

Nefize Turan Research Topics

Disease

4Inflammation (Inflammations)
03/2021 - 01/2014
3Aneurysm (Aneurysms)
05/2018 - 02/2016
2Stroke (Strokes)
03/2021 - 01/2019
2Intracranial Aneurysm (Cerebral Aneurysm)
05/2018 - 01/2018
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2018 - 01/2018
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017 - 10/2016
1Ischemic Stroke
01/2019
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019
1Intracranial Vasospasm
02/2018
1Brain Injuries (Brain Injury)
02/2018
1Rupture
01/2018
1Infections
11/2017
1Hyperglycemia
01/2017
1Body Weight (Weight, Body)
01/2017
1Granuloma
03/2016
1Siderosis
01/2016

Drug/Important Bio-Agent (IBA)

6ProgesteroneFDA LinkGeneric
03/2021 - 10/2016
2Vitamin DFDA LinkGeneric
03/2021 - 01/2019
2Hormones (Hormone)IBA
01/2019 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2014
2SteroidsIBA
01/2018 - 02/2016
1LipopolysaccharidesIBA
03/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2019
1Peroxidase (Myeloperoxidase)IBA
05/2018
1Ferrosoferric Oxide (Magnetite)FDA Link
05/2018
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2018
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2018
1Estrogens (Estrogen)FDA Link
01/2018
1Sulfates (Sulfates, Inorganic)IBA
01/2018
1Testosterone (Sustanon)FDA Link
01/2018
1Oral ContraceptivesIBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
11/2017
1Blood Glucose (Blood Sugar)IBA
01/2017
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
1CholesterolIBA
03/2016
1HemosiderinIBA
01/2016

Therapy/Procedure

2Therapeutics
03/2021 - 01/2014
1Catheters
05/2018
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2018